Pharmacologic Researchers Develop a Novel Alkylating Chemotherapeutic Agent Against Glioblastoma
Multiple Choice
Pharmacologic researchers develop a novel alkylating chemotherapeutic agent against glioblastoma multiforme. They find that malignant cells with methylation of the promoter region for the O6-methylguanine-DNA methyltransferase (MGMT) gene are more susceptible to this drug than cells without methylation. Which of the following is the most likely function of the protein encoded by the gene?
A) Induction of apoptosis
B) Reducing major histocompatibility complex expression
C) Repairing DNA damage
D) Upregulation of telomerase
Correct Answer:

Verified
Correct Answer:
Verified
Q64: A 60-year-old man comes to the office
Q65: A 10-year-old boy is brought to the
Q66: A 14-year-old boy experiences severe, prolonged bleeding
Q67: A 6-year-old boy is brought to the
Q68: In an experiment, erythrocyte precursor cells are
Q70: A healthy 31-year-old woman comes to the
Q71: A 3-year-old boy is being evaluated for
Q72: A cell biologist is studying the role
Q73: A 35-year-old woman, gravida 1 para 0,
Q74: An autopsy was performed on a 17-year-old